natgillin/translations-raw huggingface dataset:
Ligesom zidovudin udskilles nukleosidanalogerne (f.eks. didanosin) ikke ved denne mekanisme og interagerer sandsynligvis ikke med lamivudin.
The nucleoside analogues (e.g. didanosine) like zidovudine, are not eliminated by this mechanism and are unlikely to interact with lamivudine.
-2,3 % (95 % CI - 9,3 % til +4,7 %), p=0,52
-2.3% (95% CI -9.3% to +4.7%), p=0.52
Trafik- og arbejdssikkerhed Epivir påvirker sandsynligvis ikke din evne til at føre motorkøretøj eller betjene maskiner.
Driving and using machines Epivir is unlikely to affect your ability to drive or use machines.
Sæt sprøjten godt fast i tilpasningsstykket.
Insert the syringe firmly into the adapter.
Der skal tages højde for, at data vedrørende behandling med én daglig dosis er meget begrænsede hos denne population (se pkt.
It should be taken into account that data for the once daily regimen are very limited in this population (see sections 4.4, 5.1 and 5.2).
Hvide, ruderformede tabletter med delekærv, der er præget “GX CJ7” på begge sider.
White, diamond shaped scored tablets engraved with “GX CJ7” on both faces.
Dyrestudier har vist, at lamivudin ikke påvirker fertiliteten (se pkt.
Studies in animals showed that lamivudine had no effect on fertility (see section 5.3).
300 mg eller
300 mg or
30 til  50
30 to<50
Mitokondriel dysfunktion: Det er påvist in vitro og in vivo, at nukleosid- og nukleotidanaloger i forskellig udstrækning forårsager skader på mitokondrierne.
Mitochondrial dysfunction: Nucleoside and nucleotide analogues have been demonstrated in vitro and in vivo to cause a variable degree of mitochondrial damage.
Ikke almindelig: Midlertidige stigninger af leverenzymer (ASAT, ALAT) Sjælden: Hepatitis
Uncommon: Transient elevations in liver enzymes (AST, ALT) Rare: Hepatitis
Knogler, led, muskler og bindevæv Almindelig: Artralgi, muskelforstyrrelser Sjælden: Rhabdomyolyse
Musculoskeletal and connective tissue disorders Common: Arthralgia, muscle disorders Rare: Rhabdomyolysis
Patienter der skifter mellem lamivudin tabletter og lamivudin oral opløsningr bør følge dosisanbefalingerne, der gælder for den specifikke lægemiddelform (se pkt.5.2).
Patients changing between lamivudine tablets and lamivudine oral solution should follow the dosing recommendations that are specific for the formulation (see section 5.2).
Den sædvanlige dosis er 0,5 ml/kg (5 mg/kg) 2 gange daglig (med ca. 12 timers mellemrum) eller 1 ml/kg (10 mg/kg) én gang daglig.
The usual dose of Epivir is 0.5 mL/kg (5 mg/kg) twice daily (leaving approximately 12 hours between each dose), or 1 mL/kg (10 mg/kg) once daily.
Glaxo Operations U.K. Ltd (trading as Glaxo Wellcome Operations) Priory Street, Ware
Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations) Priory Street, Ware
Interaktion med trimethoprim øger ekspositionen af lamivudin med 40 % ved terapeutiske doser.
An interaction with trimethoprim, a constituent of co-trimoxazole, causes a 40 % increase in lamivudine exposure at therapeutic doses.
Grå, ruderformede og præget “GX EJ7” på den ene side.
Grey, diamond shaped and engraved with “GX EJ7” on one face
Kan forekomme hos op til 1 ud af 1.000 personer:
These may affect up to 1 in 1000 people:
Dog anbefales særlig omhu for personer i denne aldersgruppe grundet aldersrelaterede ændringer såsom nedsat nyrefunktion og ændring i hæmatologiske parametre.
Older people: No specific data are available; however, special care is advised in this age group due to age-associated changes such as the decrease in renal function and alteration of haematological parameters.
Voksne, unge og børn, der vejer mindst 25 kg:
Adults, adolescents and children who weigh at least 25 kg:
Epivir bruges til behandling af hiv-infektion (humant immundefektvirus) hos voksne og børn.
Epivir is used to treat HIV (human immunodeficiency virus) infection in adults and children.
-1,6 % (95 % CI -8,4 % til +5,2 %), p=0,65
-1.6% (95% CI -8.4% to +5.2%), p=0.65
Overvej hyppigere overvågning af hiv-1 virusmængde, når vedvarende samtidig administration ikke kan undgås (se pkt.
Consider more frequent monitoring of HIV-1 viral load when chronic coadministration cannot be avoided (see section 4.4).
HDPE beholder:
HDPE bottles:
Brug af anden medicin sammen med Epivir
Other medicines and Epivir
Lamivudin 4 mg/kg 2 gange daglig Geometrisk gennemsnit (95 % CI)
Lamivudine 4 mg/kg TwiceDaily Dosing Geometric Mean (95% Cl)
15 til  30
15 to <30
Hvis du får symptomer på en infektion, mens du tager Epivir: Kontakt straks lægen.
If you get any symptoms of infection while you are taking Epivir:
-4,8 % (95 % CI -11,5 % til +1,9 %), p=0,16
-4.8% (95% CI -11.5% to +1.9%), p=0.16
Øvrige indholdsstoffer: Sukker (saccharose 3 g/15 ml), methylparahydroxybenzoat, propylparahydroxybenzoat, vandfri citronsyre, natriumcitrat, propylenglycol, renset vand, syntetisk jordbær- og banansmagsstof.
The oral solution also contains the following other ingredients: sugar (sucrose 3 g/15 ml), methyl parahydroxybenzoate, propyl parahydroxybenzoate, anhydrous citric acid, sodium citrate, propylene glycol, water, artificial strawberry and banana flavourings.
Syntetisk jordbærsmagsstof Syntetisk banansmagsstof Renset vand
Artificial strawberry flavour Artificial banana flavour Purified water
Børn, der vejer mindst 14 kg og mindre end 20 kg:
Children weighing at least 14 kg and less than 20 kg:
Patienter der skifter mellem lamivudin oral opløsning og lamivudin tabletter bør følge dosisanbefalingerne, der gælder for den specifikke lægemiddelform (se pkt.5.2).
Patients changing between lamivudine oral solution and lamivudine tablets should follow the dosing recommendations that are specific for the formulation (see section 5.2)
Ved behandling af børn, skal en tabletformulering anvendes, hvor muligt.
Whenever possible in children, an all-tablet regimen should preferably be used.
Sjælden bivirkning, der kan ses i blodprøver: • stigning i mængden af et enzym kaldet amylase.
A rare side effect that may show up in blood tests is: • an increase in an enzyme called amylase.
Vær ekstra forsigtig med at tage Epivir
Take special care with Epivir
Den anbefalede dosis Epivir er 300 mg daglig.
The recommended dose of Epivir is 300 mg daily.
• for meget mælkesyre i blodet (laktacidose)
• Lactic acidosis (excess lactic acid in the blood)
Opportunistiske infektioner: Patienter kan fortsat udvikle opportunistiske infektioner eller andre komplikationer af hiv-infektionen, selv om de får Epivir eller anden antiretroviral behandling.
Opportunistic infections: Patients receiving Epivir or any other antiretroviral therapy may continue to develop opportunistic infections and other complications of HIV infection, and therefore should remain under close clinical observation by physicians experienced in the treatment of patients with associated HIV diseases.
10 mg/kg eller
10 mg/kg or
Én gang daglig Plasma hiv-1 RNA <80 kopier/ml: n/N (%)
Once Daily Plasma HIV-1 RNA <80 c/ml: n/N (%)
To gange daglig Plasma hiv-1 RNA <80 kopier/ml: n/N (%)
Twice Daily Plasma HIV-1 RNA <80 c/ml: n/N (%)
5.1 ARROW studie) blev der rapporteret lavere virologisk responsrater og hyppigere viral resistens hos børn, der fik oral opløsning af Epivir sammenlignet med dem, der fik tabletformuleringen.
Paediatric Population: In a study performed in paediatric patients (see section 5.1 ARROW study), lower rates of virologic suppression and more frequent viral resistance were reported in children receiving the oral solution of Epivir as compared to those receiving the tablet formulation.
Luftveje, thorax og mediastinum Almindelig: Hoste, symptomer fra næsen
Respiratory, Thoracic and mediastinal disorders Common: Cough, nasal symptoms
EU/1/96/015/001 (beholder) EU/1/96/015/004 (blisterpakning)
EU/1/96/015/001 (Bottle) EU/1/96/015/004 (Blister pack)
EU/1/96/015/003 (beholder) EU/1/96/015/005 (blisterpakning)
EU/1/96/015/003 (Bottle) EU/1/96/015/005 (Blister pack)
Produktet indeholder også sukker (saccharose 3 g/15 ml) og konserveringsmidler: methylparahydroxybenzoat og propylparahydroxybenzoat
This product also contains sugar, preservatives: methyl parahydroxybenzoate and propyl parahydroxybenzoate
Børn fra 1 år: Den anbefalede dosis er 0,5 ml/kg (5 mg/kg) 2 gange daglig eller 1 ml/kg (10 mg/kg) én gang daglig (se pkt.
Children from one year of age: The recommended dose is 0.5 mL/kg (5 mg/kg) twice daily, or 1 mL/kg (10 mg/kg) once daily (see sections 4.4 and 4.5).
Mitokondriel dysfunktion bør overvejes hos alle børn med svære kliniske symptomer af ukendt ætiologi, især neurologiske symptomer, der har været eksponeret for nukleosid-/nukleotid-analoger in utero.
These findings should be considered for any child exposed in utero to nucleoside and nucleotide analogues, who presents with severe clinical findings of unknown etiology, particularly neurologic findings.
Det vil sandsynligvis ikke give alvorlige bivirkninger, hvis du ved et uheld tager for mange Epivir.
Accidentally taking too much Epivir is unlikely to cause any serious problems.
For at undgå transmissionen af hivanbefales det, at hivinficerede kvinder under ingen omstændigheder ammer deres børn.
It is recommended that HIV infected women do not breast-feed their infants under any circumstances in order to avoid transmission of HIV.
300 mg (30 ml) 1 gang daglig eller
300 mg (30 ml) once daily or
Hypromellose (E464) Titandioxid (E171) Sort jernoxid (E172) Macrogol
Hypromellose (E464), Titanium dioxide (E171), Black iron oxide (E172),
Epivir indeholder methylparahydroxybenzoat og propylparahydroxybenzoat.
Epivir contains methyl parahydroxybenzoate and propyl parahydroxybenzoate.
• hvis du er allergisk over for lamivudin eller et af de øvrige indholdsstoffer i dette lægemiddel (angivet i punkt 6).
Do not take Epivir: • if you are allergic to lamivudine or any of the other ingredients in this medicine (listed in Section
10 mg/kg 1 gang daglig eller
10 mg/kg once daily or
Tabletten på 300 mg kan kun anvendes til engangsdosering.
The 300 mg tablet is only suitable for the once a day regimen.
Den sædvanlige dosis er 225 mg daglig.
The usual dose of Epivir is 225 mg a day.
Hver ml oral opløsning indeholder 10 mg lamivudin.
Each ml of oral solution contains 10 mg of lamivudine.
Der foreligger rapporter om mitokondriel dysfunktion hos spædbørn, som har været eksponeret for nukleosidanaloger in utero og/eller efter fødslen (se pkt.
There have been reports of mitochondrial dysfunction in infants exposed in utero and/or post-natally to nucleoside analogues (see section 4.4).
Børn, der vejer mindst 20 kg og mindre end 25 kg:
Children weighing at least 20 kg and less than 25 kg:
Gives zidovudin samtidigt, øges ekspositionen af zidovudin med 13 %, og den maksimale plasmakoncentration øges med 28 %.
Co-administration of zidovudine results in a 13% increase in zidovudine exposure and a 28 % increase in peak plasma levels.
Lamivudin 8 mg/kg én gang daglig Geometrisk gennemsnit (95 % CI)
Lamivudine 8mg/kg OnceDaily Dosing Geometric Mean (95% Cl)
Ved en terapeutisk dosis på 150 mg 2 gange daglig er den gennemsnitlige (CV) steady state, Cmax og Cmin i plasma for lamivudin henholdsvis 1,2 g/ml (24 %) og 0,09 g/ml (27 %).
Based on data derived from a study in healthy volunteers, at a therapeutic dose of 150 mg twice daily, mean (CV) steady-state Cmax and Cmin of lamivudine in plasma are 1.2 µg/ml (24%) and 0.09 µg/ml (27%), respectively.
Denne kan tages enten som 15 ml (150 mg) 2 gange daglig (med ca. 12 timers mellemrum) eller som 30 ml (300 mg) én gang daglig.
This can be taken either as 15 ml (150 mg) twice a day (leaving approximately 12 hours between each dose), or as 30 ml (300 mg) once a day.
Epivir filmovertrukne tabletter 300 mg findes i hvide polyethylenbeholdere eller blisterpakninger indeholdende 30 tabletter.
What Epivir looks like and the contents of the pack Epivir 300 mg film-coated tablets are supplied in white polyethylene bottles or blister packs containing 30 tablets.
Epivir oral opløsning fås i hvide polyethylenflasker med 240 ml opløsning.
What Epivir looks like and the contents of the pack Epivir oral solution is supplied in a white polyethylene bottle containing 240 ml of solution.
Hver ml oral opløsning indeholder 10 mg lamivudin
Each ml of oral solution contains 10 mg lamivudine
Dosisjustering af lamivudin er dog ikke nødvendig, medmindre patienten har nedsat nyrefunktion (se pkt.
However, unless the patient has renal impairment, no dosage adjustment of lamivudine is necessary (see section 4.2).
Øvrige indholdsstoffer:
The tablets also contain the following other ingredients:
150 mg (15 ml) 2 gange daglig
150 mg (15 ml) twice daily
Tal med lægen, hvis du tror, at dette gælder for dig.
Check with your doctor if you think this applies to you.
300 mg 1 gang daglig eller
300 mg once daily or
Laboratorios ViiV Healthcare S.L.
ViiV Healthcare S.r.l.
• hvis du eller dit barn har nyreproblemer, skal dosis måske justeres.
• if you or your child has a kidney problem, your dose may be altered.
60 filmovertrukne tabletter Tabletter med delekærv
60 film-coated tablets Scored tablets
Epivir tilhører en gruppe af midler rettet mod retrovirus, der kaldes nukleosidanalog revers transkriptasehæmmere (NRTI'er).
It belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors (NRTIs).
Epivir 150 mg filmovertrukne tabletter findes i hvide polyethylenbeholdere eller blisterpakninger indeholdende 60 tabletter.
What Epivir looks like and the contents of the pack Epivir 150 mg film-coated tablets are supplied in white polyethylene bottles or blister packs containing 60 tablets.
Hvis du eller dit barn har nyreproblemer, skal dosis måske justeres.
If you or your child has a kidney problem, the dose may be altered.
Særligt hos patienter med generelt anerkendte risikofaktorer, fremskreden hiv-sygdom eller langvarig kombinationsbehandling med antiretrovirale lægemidler (CART) er der rapporteret om tilfælde af osteonekrose.
Cases of osteonecrosis have been reported, particularly in patients with generally acknowledged risk factors, advanced HIV disease or long-term combined antiretroviral exposure (CART).
Triphosphatet hæmmer selektivt replikationen af hiv-1 og hiv-2 in vitro.
The triphosphate has selective inhibitory activity against HIV-1 and HIV-2 replication in vitro, it is also active against zidovudine-resistant clinical isolates of HIV.
Fortæl lægen, hvis du tager et eller flere af disse lægemidler.
Tell your doctor if you are being treated with any of these.
Epivir 10 mg/ml oral opløsning lamivudin
Epivir 10 mg/ml oral solution Lamivudine
Sådan skal du tage Epivir
How to take Epivir
Hos 1 uge gamle spædbørn var den orale clearance reduceret sammenlignet med pædiatriske patienter.
In neonates one week of age, lamivudine oral clearance was reduced when compared to paediatric patients and is likely to be due to immature renal function and variable absorption.
100 mg (10 ml) 1 gang daglig
100 mg (10 ml) once daily
Ud over bivirkninger ved Epivir nævnt nedenfor, kan du få andre sygdomme, når du får kombinationsbehandling mod hiv.
As well as the side effects listed below for Epivir, other conditions can develop during combination therapy for HIV.
25 mg (2,5 ml) 1 gang daglig
25 mg (2.5 ml) once daily
150 mg 2 gange daglig
150 mg twice daily
Pakningen indeholder en doseringssprøjte og et plasttilpasningsstykke.
An oral dosing syringe and a plastic adapter for the bottle is included in the pack.
Den sædvanlige dosis er 150 mg daglig.
The usual dose of Epivir is 150 mg a day.
Hver filmovertrukken tablet indeholder 300 mg lamivudin
Each film-coated tablet contains 300 mg lamivudine
0,9 mg/kg 1 gang daglig
0.9 mg/kg once daily
Tal med lægen, hvis noget af ovenstående gælder for dig.
Talk to your doctor if any of these apply to you.
I PENTA 15-studiet er lamivudins geometriske gennemsnits-AUC (0-24) (95 % CI) i plasma for de fire patienter under 12 måneder, som skiftede fra 2 daglige doser til én daglig dosis (se pkt.
In PENTA 15 study, the geometric mean plasma lamivudine AUC(0-24) (95% CI) of the four subjects under 12 months of age who switch from a twice daily to a once daily regimen (see section 5.1) are 10.31 (6.26, 17.0) µg.h/ml in the once-daily dosing and 9.24 (4.66, 18.3) µg.h/ml in the twice-daily dosing.
Må ikke opbevares ved temperaturer over 30 C
Do not store above 30°C
• hvis du har nyreproblemer, skal dosis måske justeres.
• if you have a kidney problem, your dose may be altered.
Denne dosis kan gives som 150 mg (15 ml) 2 gange daglig eller 300 mg (30 ml) 1 gang daglig (se pkt.
This may be administered as either 150 mg (15 ml) twice daily or 300 mg (30 ml) once daily (see section 4.4).
2-4 timer efter oral administration var det gennemsnitlige forhold mellem lamivudinkoncentrationen i cerebrospinalvæsken og plasma ca. 0,12.
The mean ratio CSF/serum lamivudine concentration 2-4 hours after oral administration was approximately 0.12.
100 mg 1 gang daglig
100 mg once daily
Hvis du har nyreproblemer, skal dosis måske justeres.
If you have a kidney problem, your dose may be altered.
Hver filmovertrukken tablet indeholder 150 mg lamivudin
Each film-coated tablet contains 150 mg lamivudine.
En dosis på 4 mg/kg/dag til spædbørn er derfor passende til at opnå samme plasmakoncentration som hos voksne og børn.
Therefore to achieve similar adult and paediatric exposure, an appropriate dose for neonates is 4 mg/kg/day.
- Lægen har ordineret dette lægemiddel til dig personligt eller til dit barn.
This medicine has been prescribed for you or for your child. Do not pass it on to others.
5 mg/kg 2 gange daglig
5 mg/kg once daily
BLISTERKARTON TIL 30 FILMOVERTRUKNE TABLETTER (300 mg)
BLISTER CARTON X 30 FILM-COATED TABLETS (300 mg )
BLISTERKARTON TIL 60 FILMOVERTRUKNE TABLETTER (150 mg)
BLISTER CARTON X 60 FILM-COATED TABLETS (150 mg)
50 mg (5 ml) 1 gang daglig
50 mg (5 ml) once daily
Hjælpestoffer, som behandleren skal være opmærksom på: Hver 150 mg tablet indeholder 0,378 mg natrium.
Each 150 mg tablet contains 0.378 mg sodium.
1,6 mg/kg 1 gang daglig
1.6 mg/kg once daily
Epivir 10 mg/ml oral opløsning.
Epivir 10 mg/ml oral solution
3,3 mg/kg 1 gang daglig
3.3 mg/kg once daily
Denne dosis kan tages enten som en 150 mg tablet 2 gange daglig (med ca. 12 timers mellemrum) eller som to 150 mg tabletter på samme tid én gang daglig.
This can be taken as either one 150 mg tablet twice a day (leaving approximately 12 hours between each dose), or two 150 mg tablets once a day as advised by your doctor.
Denne dosis kan gives som 150 mg 2 gange daglig eller 300 mg 1 gang daglig (se pkt.
This may be administered as either 150 mg twice daily or 300 mg once daily (see section 4.4).
Epivir 150 mg tabletter Lamivudin
Epivir 150 mg tablets lamivudine
150 mg (15 ml) 1 gang daglig
150 mg (15 ml) once daily
25 mg 1 gang daglig
25 mg once daily
Filmovertræk: Hypromellose, titandioxid, sort jernoxid (E172), macrogol, polysorbat 80.
Tablet core: microcrystalline cellulose, sodium starch glycollate (gluten free), magnesium stearate Film-coat: hypromellose, titanium dioxide, black iron oxide (E172), macrogol, polysorbate 80 This medicine contains less than 1 mmol sodium (23 mg) per dosage unit, that is to say essentially ‘sodium-free'.
Epivir 300 mg tabletter Lamivudin
Epivir 300 mg tablet lamivudine
Denne dosis kan gives som enten 75 mg (en halv 150 mg tablet) om morgenen og 150 mg (en hel 150 mg tablet) om aftenen eller som 225 mg (en og en halv 150 mg tablet) én gang daglig.
This may be administered as either 75 mg (one-half of a 150 mg tablet) taken in the morning and 150 mg (one whole 150 mg tablet) taken in the evening, or 225 mg (one and a half 150 mg tablets) taken once daily.
Glaxo Operations UK Limited (under forretningsnavnet Glaxo Wellcome Operations) Priory Street
Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations)
Der er rapporteret om mitokondriel dysfunktion hos hiv-negative spædbørn, som har været eksponeret for nukleosidanaloger in utero og/eller postnatalt.
There have been reports of mitochondrial dysfunction in HIV-negative infants exposed in utero and/or post-natally to nucleoside analogues, these have predominantly concerned treatment with regimens containing zidovudine.
Lamivudin metaboliseres intracellulært til den aktive del lamivudin 5-triphosphat, hvis primære virkningsmekanisme er at afslutte kæden i hiv revers-transkription.
It is metabolised intracellularly to the active moiety, lamivudine 5'triphosphate.
Denne dosis kan gives som 75 mg (en halv 150 mg tablet) 2 gange daglig eller som 150 mg (en hel 150 mg tablet) én gang daglig.
This may be administered as 75 mg (one-half of a 150 mg tablet) taken twice daily, or 150 mg (one whole 150 mg tablet) taken once daily.
Den sædvanlige dosis er 300 mg daglig.
The usual dose of Epivir is 300 mg a day.
50 mg 1 gang daglig
50 mg once daily
Kontakt lægen, før du tager denne medicin, hvis lægen har fortalt dig, at du ikke tåler visse sukkerarter.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Epivir.
Eventuelt kan patienter med synkebesvær knuse tabletterne, som herefter opblandes i en lille mængde væske eller halvflydende føde.
Alternatively, for patients who are unable to swallow tablets, the tablet(s) may be crushed and added to a small amount of semi-solid food or liquid, all of which should be consumed immediately (see section 5.2).
Til børn over 3 måneder og med en vægt på mindre end 25 kg med nedsat nyrefunktion er Epivir 10 mg/ml oral opløsning sandsynligvis den bedst egnede lægemiddelform til at opnå den anbefalede dosis.
The Epivir 10 mg/mL oral solution may be the most appropriate formulation to achieve the recommended dose in children with renal impairment aged at least 3 months and weighing less than 25kg.
Tabletterne er præget “GXEJ7” på den ene side.
They are grey, diamond shaped film-coated tablets, marked with the code ‘GXEJ7' on one side.
Denne dosis kan gives enten som 75 mg (en halv 150 mg tablet) 2 gange daglig (med ca. 12 timers mellemrum) eller som 150 mg (en hel 150 mg tablet) én gang daglig.
This can be given as 75 mg (half a 150 mg tablet) twice a day (leaving approximately 12 hours between each dose), or 150 mg (one 150 mg tablet) once a day as advised by your doctor.
Sammenligning af en versus 2 daglige doser Geometrisk gennemsnitsratio beregnet efter mindste kvadtaters metode (90 % CI)
Once-Versus Twice-Daily Comparison GLS Mean Ratio (90% Cl)
KARTON TIL BEHOLDER TIL 30 FILMOVERTRUKNE TABLETTER (300 mg)
BOTTLE CARTON X 30 FILM-COATED TABLETS (300 mg )
KARTON TIL BEHOLDER TIL 60 FILMOVERTRUKNE TABLETTER (150 mg)
BOTTLE CARTON X 60 FILM-COATED TABLETS (150 mg)
Epivir 150 mg filovertrukne tabletter
Epivir 150 mg film-coated tablets
Epivir 300 mg filovertrukne tabletter
Epivir 300 mg Film-coated tablets
ETIKET TIL BEHOLDER TIL 30 FILMOVERTRUKNE TABLETTER (300 mg)
BOTTLE LABEL X 30 FILM-COATED TABLETS (300 mg )
ETIKET TIL BEHOLDER TIL 60 FILMOVERTRUKNE TABLETTER (150 mg)
BOTTLE LABEL X 60 FILM-COATED TABLETS (150 mg)
Natriumcitrat
Breast-feeding
Kontakt lægen, skadestuen eller apoteket, hvis du har taget mere Epivir, end der står her, eller mere end lægen har foreskrevet.
If you take too much, tell your doctor or your pharmacist, or contact your nearest hospital emergency department for further advice.
Epivir 150 mg filmovertrukne tabletter lamivudin
Epivir 150 mg film-coated tablets lamivudine
Epivir 150 mg filmovertrukne tabletter Lamivudin
Epivir 150 mg film-coated tablets Lamivudine
Hvis du har taget for meget Epivir
If you take more Epivir than you should
Epivir 300 mg filmovertrukne tabletter lamivudin
Epivir 300 mg film-coated tablets Lamivudine
Indeholder 3 g sukker pr. dosis (150 mg = 15 ml).
If you are a diabetic, please note that each dose (150 mg = 15 ml) contains 3 g sugar.
Epivir 300 mg fimovertrukne tabletter
Epivir 300 mg film-coated tablets
Tag ikke Epivir
Do not store Epivir above 30
• almen utilpashed
• general feeling of being unwell
Der er ingen eller utilstrækkelige data fra anvendelse af ivabradin til gravide kvinder.
Pregnancy There are no or limited amount of data from the use of ivabradine in pregnant women.